National Health (Price and Special Patient Contribution) Determination 2010 (No. PB 109 of 2010) (Cth)

Case
No judgment structure available for this case.

National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)

made under section 85B of the

National Health Act 1953

Compilation No. 46

Compilation date:    1 June 2016

Includes amendments up to:            PB 42 of 2016

Registered:   7 June 2016

About this compilation

This compilation

This is a compilation of the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010) that shows the text of the law as amended and in force on 1 June 2016 (the compilation date).

The notes at the end of this compilation (the endnotes) include information about amending laws and the amendment history of provisions of the compiled law.

Uncommenced amendments

The effect of uncommenced amendments is not shown in the text of the compiled law. Any uncommenced amendments affecting the law are accessible on the Legislation Register ( The details of amendments made up to, but not commenced at, the compilation date are underlined in the endnotes. For more information on any uncommenced amendments, see the series page on the Legislation Register for the compiled law.

Application, saving and transitional provisions for provisions and amendments

If the operation of a provision or amendment of the compiled law is affected by an application, saving or transitional provision that is not included in this compilation, details are included in the endnotes.

Editorial changes

For more information about any editorial changes made in this compilation, see the endnotes.

Modifications

If the compiled law is modified by another law, the compiled law operates as modified but the modification does not amend the text of the law. Accordingly, this compilation does not show the text of the compiled law as modified. For more information on any modifications, see the series page on the Legislation Register for the compiled law.

Self-repealing provisions

If a provision of the compiled law has been repealed in accordance with a provision of the law, details are included in the endnotes.

Contents

1............ Name of Determination................................................................................................. 1

2............ Commencement............................................................................................................. 1

3............ Revocation..................................................................................................................... 1

4............ Definitions..................................................................................................................... 1

5............ Determined price........................................................................................................... 1

6............ Claimed price................................................................................................................. 2

7............ Commonwealth payment of special patient contribution................................................ 2

Schedule 1—Determined and Claimed Prices  3

Schedule 2—Pharmaceutical benefits for which the Commonwealth will pay the special patient contribution  31

Endnotes33

Endnote 1—About the endnotes  33

Endnote 2—Abbreviation key  34

Endnote 3—Legislation history  35

Endnote 4—Amendment history  38

1  Name of Determination

(1)  This Determination is the National Health (Price and Special Patient Contribution) Determination 2010.

(2)  This Determination may also be cited as PB 109 of 2010.

2  Commencement

This Determination commences on 1 December 2010.

3  Revocation

Instrument PB 72 of 2010 is revoked.

4  Definitions

(1)  In this Determination:

Act means the National Health Act 1953.

approved ex‑manufacturer price has the same meaning as in subsection 84(1) of the Act.

base‑priced drug in relation to a brand of a pharmaceutical item mentioned in Schedule 2 (the relevant brand), means all brands of pharmaceutical items that have:

(a)  the same drug as the relevant brand; or

(b)  a drug in the same therapeutic group as that drug; and

for which no price is determined under section 85B of the Act.

pack quantity has the same meaning as in subsection 84(1) of the Act.

Note:          The Minister may determine one or more pack quantities for a brand of a pharmaceutical item under subsection 84AK(2) of the Act. The quantities determined are the quantities in manufacturer’s PBS packs.

pricing quantity has the same meaning as in subsection 84(1) of the Act.

Note: Subsection 84AK(1) of the Act provides that the pricing quantity of a brand of a pharmaceutical item is the lowest pack quantity of any brand of the pharmaceutical item.

special patient contribution has the meaning given by subsection 85B(5) of the Act.

5  Determined price

For subsection 85B(2) of the Act, the amount that is, for the purposes of Part VII of the Act, taken to be the appropriate maximum price for the pricing quantity of a brand of a pharmaceutical item mentioned in Schedule 1, is the price for the brand mentioned in the column headed ‘Determined Price’ for the pricing quantity mentioned in the column headed ‘Pricing Quantity/Pack Quantity’.

6  Claimed price

For subsection 85B(3) of the Act, the amount that is, for the purposes of Part VII of the Act, taken to be the price claimed by the responsible person for a pack quantity of a brand of a pharmaceutical item mentioned in Schedule 1, is the price for the brand mentioned in the column headed ‘Claimed Price’ for the pack quantity mentioned in the column headed ‘Pricing Quantity/Pack Quantity’.

7  Commonwealth payment of special patient contribution

(1) For subsection 85B(4) of the Act, the circumstances in which the Commonwealth is to pay the special patient contribution for a brand of a pharmaceutical item are:

(a)  the brand of pharmaceutical item is mentioned in Schedule 2; and

(b)  the brand has been prescribed in a circumstance mentioned for the brand in Schedule 2; and

(c)  the prescription has been authorised by the Chief Executive Medicare in accordance with subsection (2) or (3).

(2) If the circumstance in which the brand is prescribed is a circumstance determined under paragraph 85(7)(b) of the Act, the prescription is taken to be authorised if:

(a)  the circumstance requires compliance with authority required procedures for prescribing the brand; and

(b)  the authority required procedures have been complied with.

(3) In any other case, a prescription is taken to be authorised if the prescription has been submitted and authorised in the way provided for in authority required procedures mentioned in an instrument made under section 85 of the Act.

(4)  For this section, the pharmaceutical item is the listed drug mentioned in Schedule 2:

(a)  in the form mentioned in Schedule 2 for the listed drug; and

(b)  with the manner of administration mentioned in Schedule 2 for the form of the listed drug.

Schedule 1—Determined and Claimed Prices

Listed Drug Form Manner of Administration Brand Pricing Quantity/Pack Quantity Determined
Price
$ 		Claimed
 Price
$
Aciclovir Tablet 200 mg Oral Zovirax 200 mg 25 8.30 8.96
90 30.99
Tablet 800 mg Oral Zovirax 800 mg 35 36.15 36.70
Alendronic acid with colecalciferol Tablet 70 mg (as alendronate sodium) with 70 micrograms colecalciferol Oral Fosamax Plus 4 26.91 29.23
Tablet 70 mg (as alendronate sodium) with 140 micrograms colecalciferol Oral Fosamax Plus 70 mg/140 mcg 4 26.91 29.22
Alendronic acid with colecalciferol and calcium Pack containing 4 tablets containing alendronic acid 70 mg (as alendronate sodium) with 140 micrograms colecalciferol and 48 tablets calcium 500 mg (as carbonate) Oral Fosamax Plus
D-Cal 		4 27.50 29.83
Allopurinol Tablet 100 mg Oral Zyloprim 100 1.84 -
200 - 6.91
Amitriptyline Tablet containing amitriptyline hydrochloride 10 mg Oral Endep 10 50 2.33 4.15
Tablet containing amitriptyline hydrochloride 25 mg Oral Endep 25 50 2.51 4.33
Tablet containing amitriptyline hydrochloride 50 mg Oral Endep 50 50 2.88 4.70
Tablet 300 mg Oral Zyloprim 60 2.16 5.39
Amlodipine Tablet 5 mg (as besylate) Oral Norvasc 30 1.00 6.85
Tablet 10 mg (as besylate) Oral Norvasc 30 1.76 9.34
Amoxycillin Capsule 250 mg (as trihydrate) Oral Amoxil 20 0.62 3.87
Capsule 500 mg (as trihydrate) Oral Amoxil 20 1.24 4.73
Powder for oral suspension 125 mg (as trihydrate) per 5 mL, 100 mL Oral Amoxil 1 0.55 3.77
Powder for oral suspension 250 mg (as trihydrate) per 5 mL, 100 mL Oral Amoxil Forte 1 0.80 4.11
Powder for paediatric oral drops 100 mg (as trihydrate) per mL, 20 mL Oral Amoxil 1 3.42 3.92
Tablet 1 g (as trihydrate) Oral Maxamox 14 1.27 1.61
Amoxycillin with Clavulanic Acid Powder for oral suspension containing 125 mg amoxycillin (as trihydrate) with 31.25 mg clavulanic acid (as potassium clavulanate) per 5 mL, 75 mL Oral Augmentin 1 1.11 4.32
Powder for oral suspension containing 400 mg amoxycillin (as trihydrate) with 57 mg clavulanic acid (as potassium clavulanate) per 5 mL, 60 mL Oral Augmentin Duo 400 1 1.59 6.09
Tablet containing 500 mg amoxycillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral Augmentin Duo 10 1.81 6.34
Tablet containing 875 mg amoxycillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral Augmentin Duo forte 10 2.58 8.38
Atenolol Tablet 50 mg Oral Tenormin 30 1.06 3.33
Betamethasone Cream 200 micrograms (as valerate) per g, 100 g Application Betnovate 1/5 1 7.20 9.98
Celestone-M 1 7.20 8.35
Cream 500 micrograms (as dipropionate) per g, 15 g Application Diprosone 1 5.43 7.71
Cream 500 micrograms (as valerate) per g, 15 g Application Betnovate 1/2 1 1.61 3.99
Ointment 500 micrograms (as dipropionate) per g, 15 g Application Diprosone 1 5.43 7.71
Betaxolol Eye drops, solution, 5 mg (as hydrochloride) per mL, 5 mL Application to the eye Betoptic 1 6.75 9.62
Bisacodyl Suppositories 10 mg, 10 Rectal Dulcolax 1 3.92 4.32
Bisoprolol Tablet containing bisoprolol fumarate 2.5 mg Oral Bicor 28 10.64 13.96
Tablet containing bisoprolol fumarate 5 mg Oral Bicor 28 13.30 16.62
Tablet containing bisoprolol fumarate 10 mg Oral Bicor 28 16.63 19.95
Brimonidine Eye drops containing brimonidine tartrate 2 mg per mL, 5 mL Application to the eye Alphagan 1 11.10 12.42
Brinzolamide Eye drops 10 mg per mL, 5 mL Application to the eye Azopt 1 13.23 15.35
Candesartan Tablet containing candesartan cilexetil 4 mg Oral Atacand 30 0.74 2.60
Tablet containing candesartan cilexetil 8 mg Oral Atacand 30 2.20 4.06
Tablet containing candesartan cilexetil 16 mg Oral Atacand 30 6.58 8.44
Tablet containing candesartan cilexetil 32 mg Oral Atacand 30 7.95 9.81
Candesartan with Hydrochlorothiazide Tablet containing candesartan cilexetil 16 mg with hydrochlorothiazide 12.5 mg Oral Atacand Plus 16/12.5 30 8.09 9.95
Tablet containing candesartan cilexetil 32 mg with hydrochlorothiazide 12.5 mg Oral Atacand Plus 32/12.5 30 9.46 11.32
Tablet containing candesartan cilexetil 32 mg with hydrochlorothiazide 25 mg Oral Atacand Plus 32/25 30 10.97 12.83
Captopril Tablet 12.5 mg Oral Zedace 90 4.30 7.97
Tablet 25 mg Oral Capoten 90 6.22 9.83
Zedace 90 6.22 9.90
Tablet 50 mg Oral Capoten 90 12.27 15.07
Zedace 90 12.27 15.94
Carbamazepine Tablet 100 mg Oral Tegretol 100 100 4.88 6.26
Tablet 200 mg Oral Tegretol 200 100 9.13 10.51
Carbomer Eye gel 2 mg per g, 10 g Application to the eye Viscotears 1 2.62 6.20
Carmellose Eye drops containing carmellose sodium 5 mg per mL, single dose units 0.4 mL, 30 Application to the eye Cellufresh 1 6.37 8.63
Eye drops containing carmellose sodium 10 mg per mL, single dose units 0.4 mL, 30 Application to the eye Celluvisc 1 6.37 8.63
Cefaclor Powder for oral suspension 125 mg (as monohydrate) per 5 mL, 100 mL Oral Ceclor 1 2.17 6.91
Powder for oral suspension 250 mg (as monohydrate) per 5 mL, 75 mL Oral Ceclor 1 2.33 7.27
Tablet (sustained release) 375 mg (as monohydrate) Oral Ceclor CD 10 3.10 8.92
Cephalexin Capsule 250 mg (anhydrous) Oral Keflex 20 0.81 4.31
Capsule 500 mg (anhydrous) Oral Keflex 20 1.46 6.55
Granules for oral suspension 125 mg per 5 mL, 100 mL Oral Keflex 1 0.97 4.83
Granules for oral suspension 250 mg per 5 mL, 100 mL Oral Keflex 1 1.45 6.74
Ciprofloxacin Eye drops 3 mg (as hydrochloride) per mL, 5 mL Application to the eye Ciloxan 1 8.92 10.39
Tablet 250 mg (as hydrochloride) Oral Ciproxin 250 14 3.60 5.55
Tablet 500 mg (as hydrochloride) Oral Ciproxin 500 14 7.03 9.76
Citalopram Tablet 20 mg (as hydrobromide) Oral Cipramil 28 1.60 7.40
Clarithromycin Tablet 250 mg Oral Klacid 14 2.47 5.73
Clindamycin Capsule 150 mg (as hydrochloride) Oral Dalacin C 24 7.87 14.47
Clomipramine Tablet containing clomipramine hydrochloride 25 mg Oral Anafranil 25 50 6.25 8.80
Clonazepam Tablet 2 mg Oral Rivotril 100 9.96 11.52
Tablet 500 micrograms Oral Rivotril 100 5.29 6.67
Codeine with Paracetamol Tablet containing codeine phosphate 30 mg with paracetamol 500 mg Oral Codapane Forte 20 0.74 0.92
Panadeine Forte 20 0.74 2.69
Colchicine Tablet 500 micrograms Oral Colgout 30 3.70 6.40
Cyproterone Tablet containing cyproterone acetate 50 mg Oral Androcur 20 17.01 19.85
50 - 43.87
Tablet containing cyproterone acetate 100 mg Oral Androcur-100 50 66.25 67.92
Dexamethasone with Framycetin and Gramicidin Ear drops containing dexamethasone 500 micrograms (as sodium metasulfobenzoate), framycetin sulfate 5 mg and gramicidin 50 micrograms per mL, 8 mL Application to the ear Sofradex 1 2.85 4.39
Diazepam Tablet 5 mg Oral Valium 50 1.03 3.07
Diclofenac Tablet (enteric coated) containing diclofenac sodium 25 mg Oral Voltaren 25 50 1.56 2.70
Tablet (enteric coated) containing diclofenac sodium 50 mg Oral Voltaren 50 50 2.17 4.45
Digoxin Tablet 62.5 micrograms Oral Lanoxin-PG 200 3.24 5.62
Tablet 250 micrograms Oral Lanoxin 100 3.47 5.85

Diphenoxylate with Atropine

Tablet containing diphenoxylate hydrochloride 2.5 mg with atropine sulfate 25 micrograms

Oral

Lomotil

20

1.66

3.06

Doxepin

Capsule 10 mg (as hydrochloride)

Oral

Sinequan

50

2.69

7.87
Capsule 25 mg (as hydrochloride) Oral Sinequan 50 2.79 7.86
Doxycycline Capsule 100 mg (as hydrochloride) (containing enteric coated pellets) Oral Doryx 7 0.88 3.64
Mayne Pharma Doxycycline 7 0.88 2.32
Doryx 21 - 11.01
Mayne Pharma Doxycycline 21 - 5.63
Capsule 50 mg (as hydrochloride) (containing enteric coated pellets) Oral Doryx 25 1.57 6.23
Mayne Pharma Doxycycline 25 1.57 3.98
Duloxetine Capsule 30 mg (as hydrochloride) Oral Cymbalta 28 6.08 8.87
Capsule 60 mg (as hydrochloride) Oral Cymbalta 28 8.67 11.46
Enalapril Tablet containing enalapril maleate 10 mg Oral Renitec 30 3.74 8.06
Tablet containing enalapril maleate 20 mg Oral Renitec 20 30 4.76 9.10
Eprosartan Tablet 400 mg (as mesylate) Oral Teveten 28 5.75 9.00
Tablet 600 mg (as mesylate) Oral Teveten 28 14.41 17.66
Erythromycin Capsule 250 mg (containing enteric coated pellets) Oral Eryc 25 4.45 6.80
Powder for oral liquid 200 mg (as ethyl succinate) per 5 mL, 100 mL Oral E.E.S. 200 1 4.46 6.66
Powder for oral liquid 400 mg (as ethyl succinate) per 5 mL, 100 mL Oral E.E.S. Granules 1 5.68 7.90
Tablet 400 mg (as ethyl succinate) Oral E.E.S. 400 Filmtab 25 4.56 6.72
Escitalopram Tablet 10 mg (as oxalate) Oral Lexapro 28 2.73 9.28
Tablet 20 mg (as oxalate) Oral Lexapro 28 2.75 9.62
Exemestane Tablet 25 mg Oral Aromasin 30 71.67 73.25
Felodipine Tablet 2.5 mg (extended release) Oral Plendil ER 30 3.00 5.23
Tablet 5 mg (extended release) Oral Plendil ER 30 4.32 6.55
Tablet 10 mg (extended release) Oral Plendil ER 30 7.82 10.05
Fluoxetine Capsule 20 mg (as hydrochloride) Oral Prozac 20 28 3.98 5.25
Tablet, dispersible, 20 mg (as hydrochloride) Oral Prozac Tab 28 3.98 5.25
Fluvoxamine Tablet containing fluvoxamine maleate 50 mg Oral Luvox 30 5.97 9.23
Tablet containing fluvoxamine maleate 100 mg Oral Luvox 30 9.05 12.30
Frusemide Tablet 20 mg Oral Lasix-M 50 0.62 1.30
Tablet 40 mg Oral Lasix 100 1.13 2.85
Glibenclamide Tablet 5 mg Oral Daonil 100 4.02 5.18
Gliclazide Tablet 60 mg (modified release) Oral Diamicron 60mg MR 60 6.73 8.55
Glimepiride Tablet 1 mg Oral Amaryl 30 1.02 3.10
Tablet 2 mg Oral Amaryl 30 1.95 3.98
Tablet 3 mg Oral Amaryl 30 2.48 4.52
Tablet 4 mg Oral Amaryl 30 3.05 5.09
Glipizide Tablet 5 mg Oral Minidiab 100 6.34 13.33
Glyceryl Trinitrate Tablets 600 micrograms, 100 Buccal/sublingual Anginine Stabilised 1 6.80 9.18
Hydrocortisone Cream containing hydrocortisone acetate 10 mg per g, 50 g Application Sigmacort 1 1.73 3.92
Ointment containing hydrocortisone acetate 10 mg per g, 50 g Application Sigmacort 1 1.73 3.92
Hypromellose Eye drops 3 mg per mL, 15 mL Application to the eye Genteal 1 3.12 5.79
Hypromellose with Carbomer 980 Ocular lubricating gel 3 mg-2 mg per g, 10 g Application to the eye Genteal gel 1 3.12 5.79
Hypromellose with Dextran Eye drops containing 3 mg hypromellose 4500 with 1 mg dextran 70 per mL, 15 mL Application to the eye Tears Naturale 1 3.29 6.69
Imipramine Tablet containing imipramine hydrochloride 10 mg Oral Tofranil 10 50 1.71 3.97
Tablet containing imipramine hydrochloride 25 mg Oral Tofranil 25 50 4.86 7.11
Imiquimod Cream 50 mg per g, 2 g, 2 Application Aldara Pump 1 83.11 88.11
Cream 50 mg per g, 250 mg single use sachets, 12 Application Aldara 1 83.11 85.61
Indapamide Tablet containing indapamide hemihydrate 2.5 mg Oral Natrilix 90 7.14 10.97
Indomethacin Capsule 25 mg Oral Indocid 50 2.60 4.48
Ipratropium Nebuliser solution containing ipratropium bromide 250 micrograms (anhydrous) in 1 mL single dose units, 30 Inhalation Atrovent 1 8.71 8.94
Nebuliser solution containing ipratropium bromide 500 micrograms (anhydrous) in 1 mL single dose units, 30 Inhalation Atrovent Adult 1 10.29 10.52
Irbesartan Tablet 75 mg Oral Avapro 30 1.96 3.73
Karvea 30 1.96 3.73
Tablet 150 mg Oral Avapro 30 2.80 4.57
Karvea 30 2.80 4.57
Tablet 300 mg Oral Avapro 30 5.58 7.35
Karvea 30 5.58 7.35
Irbesartan with hydrochlorothiazide Tablet 150 mg-12.5 mg Oral Avapro HCT 150/12.5 30 3.98 5.75
Karvezide 150/12.5 30 3.98 5.75
Tablet 300 mg-12.5 mg Oral Avapro HCT 300/12.5 30 7.09 8.85
Karvezide 300/12.5 30 7.09 8.85
Tablet 300 mg-25 mg Oral Avapro HCT 300/25 30 7.96 9.73
Karvezide 300/25 30 7.96 9.73
Isosorbide Mononitrate Tablet 60 mg (sustained release) Oral Imdur Durule 30 3.22 6.35
Monodur 60 mg 30 3.22 5.52
Tablet 120 mg (sustained release) Oral Imdur 120 mg 30 7.61 10.74
Ketoprofen Capsule 200 mg (sustained release) Oral Orudis SR 200 28 10.26 12.04
Labetalol Tablet containing labetalol hydrochloride 100 mg Oral Trandate 100 7.79 11.05
Tablet containing labetalol hydrochloride 200 mg Oral Trandate 100 12.32 15.58
Lamotrigine Tablet 5 mg Oral Lamictal 56 3.60 5.20
Tablet 25 mg Oral Lamictal 56 6.38 8.23
Tablet 50 mg Oral Lamictal 56 10.64 12.29
Tablet 100 mg Oral Lamictal 56 17.71 19.43
Tablet 200 mg Oral Lamictal 56 29.77 31.49
Lansoprazole Tablet 15 mg (orally disintegrating) Oral Zoton FasTabs 28 4.57 10.05
Tablet 30 mg (orally disintegrating) Oral Zoton FasTabs 28 8.22 13.70
Lercanidipine Tablet containing lercanidipine hydrochloride 10 mg Oral Zanidip 28 2.47 5.73
Tablet containing lercanidipine hydrochloride 20 mg Oral Zanidip 28 4.12 7.38
Levodopa with Carbidopa Tablet 100 mg-25 mg (anhydrous) Oral Sinemet 100/25 100 25.77 30.28
Levonorgestrel with Ethinyloestradiol Pack containing 21 tablets 150 micrograms-30 micrograms and 7 inert tablets Oral Microgynon 30 ED 4 7.18 17.79
Nordette 28 4 7.18 18.81
Pack containing 6 tablets 50 micrograms-30 micrograms, 5 tablets 75 micrograms-40 micrograms, 10 tablets 125 micrograms-30 micrograms and 7 inert tablets Oral Triphasil 28 4 7.18 18.81
Triquilar ED 4 7.18 17.79
Lisinopril Tablet 5 mg Oral Zestril 30 2.34 5.41
Tablet 10 mg Oral Prinivil 10 30 3.50 5.81
Zestril 30 3.50 6.22
Tablet 20 mg Oral Prinivil 20 30 4.41 6.72
Zestril 30 4.41 7.16
Loperamide Capsule containing loperamide hydrochloride 2 mg Oral Imodium 12 1.39 1.99
Medroxyprogesterone Injection containing medroxyprogesterone acetate 150 mg in 1 mL Injection Depo-Provera 1 13.14 18.15
Tablet containing medroxyprogesterone acetate 5 mg Oral Provera 56 7.44 12.64
Tablet containing medroxyprogesterone acetate 10 mg Oral Provera 30 6.39 11.59
100 - 26.51
Meloxicam Capsule 7.5 mg Oral Mobic 30 3.23 5.55
Capsule 15 mg Oral Mobic 30 4.71 7.03
Tablet 7.5 mg Oral Mobic 30 3.23 5.55
Tablet 15 mg Oral Mobic 30 4.71 7.03
Metformin Tablet containing metformin hydrochloride 500 mg Oral Diabex 100 2.79 6.37
Tablet (extended release) containing metformin hydrochloride 500 mg Oral Diabex XR 120 4.47 8.05
Tablet containing metformin hydrochloride 850 mg Oral Diabex 850 60 2.79 6.37
Glucophage 60 2.79 3.25
Tablet containing metformin hydrochloride 1 g Oral Diabex 1000 90 4.86 8.44
Tablet (extended release) containing metformin hydrochloride 1 g Oral Diabex XR 1000 60 4.47 8.05
Methyldopa Tablet 250 mg Oral Aldomet 100 8.18 11.05
Methylprednisolone Injection containing methylprednisolone acetate 40 mg in 1 mL Injection Depo-Medrol 5 12.15 14.48
Metoclopramide Tablet containing metoclopramide hydrochloride 10 mg Oral Maxolon 25 1.05 2.83
Metoprolol Tablet containing metoprolol tartrate 50 mg Oral Betaloc 100 1.98 5.48
Lopresor 50 100 1.98 3.85
Tablet containing metoprolol tartrate 100 mg Oral Betaloc 60 2.52 6.02
Lopresor 100 60 2.52 4.38
Metronidazole Tablet 200 mg Oral Flagyl 21 1.18 3.04
Tablet 400 mg Oral Flagyl 21 2.77 4.63
Minocycline Tablet 50 mg (as hydrochloride) Oral Minomycin-50 60 6.98 8.51
Mirtazapine Tablet 15 mg (orally disintegrating) Oral Avanza SolTab 30 4.52 5.64
Tablet 30 mg Oral Avanza 30 3.93 7.19
Tablet 30 mg (orally disintegrating) Oral Avanza SolTab 30 6.02 7.13
Tablet 45 mg Oral Avanza 30 6.55 9.80
Tablet 45 mg (orally disintegrating) Oral Avanza SolTab 30 9.07 10.18
Moclobemide Tablet 150 mg Oral Aurorix 60 5.16 5.46
Tablet 300 mg Oral Aurorix 300 mg 60 9.93 10.53
Mometasone Cream containing mometasone furoate 1 mg per g, 15 g Application Elocon 1 3.85 6.36
Lotion containing mometasone furoate 1 mg per g, 30 mL Application Elocon 1 6.07 8.58
Ointment containing mometasone furoate 1 mg per g, 15 g Application Elocon 1 3.85 6.36
Montelukast Tablet, chewable, 4 mg (as sodium) Oral Singulair 28 12.39 14.25
Naproxen Tablet 250 mg Oral Naprosyn 50 3.38 4.42
Tablet 500 mg Oral Naprosyn 50 4.99 6.04
Tablet 1 g (sustained release) Oral Naprosyn SR1000 28 6.10 7.14
Tablet 750 mg (sustained release) Oral Naprosyn SR750 28 4.58 5.56
Tablet containing naproxen sodium 550 mg Oral Anaprox 550 50 5.13 6.89
Naratriptan Tablet 2.5 mg (as hydrochloride) Oral Naramig 2 7.49 8.55
Nifedipine Tablet 10 mg Oral Adalat 10 60 5.20 6.91
Tablet 20 mg Oral Adalat 20 60 6.40 8.79
Tablet 30 mg (controlled release) Oral Adalat Oros 30 30 7.19 9.81
Tablet 60 mg (controlled release) Oral Adalat Oros 60 30 9.03 11.81
Nitrazepam Tablet 5 mg Oral Mogadon 25 1.50 2.65
Nizatidine Capsule 150 mg Oral Tazac 60 9.71 14.02
Capsule 300 mg Oral Tazac 30 9.71 14.02
Norethisterone with Ethinyloestradiol Pack containing 21 tablets 500 micrograms-35 micrograms and 7 inert tablets Oral Brevinor 4 8.12 16.75
Pack containing 21 tablets 1 mg-35 micrograms and 7 inert tablets Oral Brevinor-1 4 8.12 16.75
Olmesartan Tablet containing olmesartan medoxomil 20 mg Oral Olmetec 30 7.43 10.69
Tablet containing olmesartan medoxomil 40 mg Oral Olmetec 30 15.76 19.02
Omeprazole Tablet 20 mg (as magnesium) Oral Losec Tablets 30 4.74 7.59
Oxazepam Tablet 15 mg Oral Serepax 25 1.32 3.79
Tablet 30 mg Oral Serepax 25 1.00 3.17
Paraffin Pack containing 2 tubes eye ointment, compound, containing white soft paraffin with liquid paraffin, 3.5 g Application to the eye Refresh Night Time 1 11.47 13.18
Paroxetine Tablet 20 mg (as hydrochloride) Oral Aropax 30 4.59 6.63
Perindopril Tablet containing perindopril arginine 2.5 mg Oral Coversyl 2.5mg 30 2.05 3.86
PREXUM 2.5 30 2.05 3.86
Perindopril with amlodipine Tablet containing 5 mg perindopril arginine with 5 mg amlodipine (as besylate) Oral Coveram 5/5 30 4.82 6.63
Tablet containing 5 mg perindopril arginine with 10 mg amlodipine (as besylate) Oral Coveram 5/10 30 5.58 10.18
Tablet containing 10 mg perindopril arginine with 5 mg amlodipine (as besylate) Oral Coveram 10/5 30 6.85 8.67
Tablet containing 10 mg perindopril arginine with 10 mg amlodipine (as besylate) Oral Coveram 10/10 30 7.61 9.41
Phenoxymethylpenicillin Oral suspension 150 mg (as benzathine) per 5 mL, 100 mL Oral Abbocillin-V 1 6.14 6.91
Piroxicam Capsule 10 mg Oral Feldene 50 4.68 10.33
Capsule 20 mg Oral Feldene 25 4.45 9.90
Dispersible tablet 20 mg Oral Feldene-D 25 4.45 10.83
Pravastatin Tablet containing pravastatin sodium 10 mg Oral Pravachol 30 1.72 2.68
Tablet containing pravastatin sodium 20 mg Oral Pravachol 30 2.73 3.69
Tablet containing pravastatin sodium 40 mg Oral Pravachol 30 4.24 5.25
Tablet containing pravastatin sodium 80 mg Oral Pravachol 30 6.52 7.54
Prednisolone Oral solution 5 mg (as sodium phosphate) per mL, 30 mL Oral Redipred 1 6.70 8.88
Tablet 1 mg Oral Panafcortelone 100 1.54 2.20
Prednisone Tablet 1 mg Oral Panafcort 100 1.97 2.71
Prochlorperazine Tablet containing prochlorperazine maleate 5 mg Oral Stemetil 25 1.15 3.94
Propranolol Tablet containing propranolol hydrochloride 10 mg Oral Inderal 100 2.56 6.05
Tablet containing propranolol hydrochloride 40 mg Oral Inderal 100 2.81 6.30
Quinapril Tablet 5 mg (as hydrochloride) Oral Accupril 30 2.91 5.79
Tablet 10 mg (as hydrochloride) Oral Accupril 30 4.16 7.05
Tablet 20 mg (as hydrochloride) Oral Accupril 30 5.14 8.03
Ranitidine Tablet 150 mg (as hydrochloride) Oral Zantac 60 3.85 6.14
Tablet 300 mg (as hydrochloride) Oral Zantac 30 3.85 6.14
Tablet, effervescent, 150 mg (as hydrochloride) Oral Zantac 30 2.17 2.82
Roxithromycin Tablet 150 mg Oral Rulide 10 1.56 3.07
Tablet 300 mg Oral Rulide 5 1.56 3.07
Salbutamol Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 30 Inhalation Asmol 2.5 uni-dose 1 3.72 3.95
Ventolin Nebules 1 3.72 4.20
Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 30 Inhalation Asmol 5 uni-dose 1 3.92 4.15
Ventolin Nebules 1 3.92 4.38
Pressurised inhalation 100 micrograms (as sulfate) per dose, 200 doses (CFC-free formulation) Inhalation by mouth Ventolin CFC-free 1 2.99 3.93
Sertraline Tablet 50 mg (as hydrochloride) Oral Zoloft 30 1.86 6.77
Tablet 100 mg (as hydrochloride) Oral Zoloft 30 1.86 6.77
Simvastatin Tablet 10 mg Oral Lipex 10 30 1.38 6.03
Zocor 30 1.38 6.03
Tablet 20 mg Oral Lipex 20 30 2.00 6.65
Zocor 30 2.00 6.65
Tablet 40 mg Oral Lipex 40 30 2.87 7.52
Zocor 30 2.87 7.52
Tablet 80 mg Oral Lipex 80 30 4.12 8.77
Zocor 30 4.12 8.77
Sotalol Tablet containing sotalol hydrochloride 80 mg Oral Sotacor 60 3.41 6.09
Tablet containing sotalol hydrochloride 160 mg Oral Sotacor 60 7.32 10.01
Spironolactone Tablet 25 mg Oral Aldactone 100 4.67 9.87
Tablet 100 mg Oral Aldactone 100 18.36 24.10
Sucralfate Tablet equivalent to 1 g anhydrous sucralfate Oral Carafate 120 13.81 15.67
Sulfasalazine Tablet 500 mg (enteric coated) Oral Salazopyrin-EN 100 20.15 21.77
Sumatriptan Tablet 50 mg (as succinate) Oral Imigran 2 3.22 4.87
4 9.75
Tablet (fast disintegrating) 50 mg (as succinate) Oral Imigran FDT 2 3.22 4.87
Tamoxifen Tablet 20 mg (as citrate) Oral Nolvadex-D 30 10.53 11.55
Telmisartan Tablet 40 mg Oral Micardis 28 3.34 4.84
Tablet 80 mg Oral Micardis 28 9.67 11.17
Telmisartan with amlodipine Tablet 40 mg-5 mg (as besylate) Oral Twynsta 28 4.27 5.77
Tablet 40 mg-10 mg (as besylate) Oral Twynsta 28 4.98 6.48
Tablet 80 mg-5 mg (as besylate) Oral Twynsta 28 10.60 12.10
Tablet 80 mg-10 mg (as besylate) Oral Twynsta 28 11.31 12.81
Telmisartan with hydrochlorothiazide Tablet 40 mg-12.5 mg Oral Micardis Plus 40/12.5 28 4.45 5.95
Tablet 80 mg-12.5 mg Oral Micardis Plus 80/12.5 28 11.08 12.58
Tablet 80 mg-25 mg Oral Micardis Plus 80/25 28 12.07 13.57
Temazepam Tablet 10 mg Oral Normison 25 0.75 3.99
Thyroxine Tablet containing 50 micrograms anhydrous thyroxine sodium Oral Oroxine 200 13.71 15.49
Tablet containing 75 micrograms anhydrous thyroxine sodium Oral Oroxine 200 14.23 16.07
Tablet containing 100 micrograms anhydrous thyroxine sodium Oral Oroxine 200 14.20 15.99
Tablet containing 200 micrograms anhydrous thyroxine sodium Oral Oroxine 200 16.65 18.44
Timolol Eye drops 5 mg (as maleate) per mL, 5 mL Application to the eye Timoptol 1 4.76 7.22
Tinidazole Tablet 500 mg Oral Fasigyn 4 3.53 7.91
Tramadol Capsule containing tramadol hydrochloride 50 mg Oral Tramal 20 0.93 3.18
Tablet (sustained release) containing tramadol hydrochloride 100 mg Oral Tramal SR 100 20 2.53 6.71
Tablet (sustained release) containing tramadol hydrochloride 150 mg Oral Tramal SR 150 20 3.40 8.40
Tablet (sustained release) containing tramadol hydrochloride 200 mg Oral Tramal SR 200 20 4.14 9.79
Trandolapril Capsule 500 micrograms Oral Gopten 28 1.39 4.64
Capsule 1 mg Oral Gopten 28 3.69 6.95
Capsule 2 mg Oral Gopten 28 4.45 7.70
Capsule 4 mg Oral Gopten 28 8.36 11.61
Triamcinolone Cream containing triamcinolone acetonide 200 micrograms per g, 100 g Application Aristocort 0.02% 1 3.23 4.75
Ointment containing triamcinolone acetonide 200 micrograms per g, 100 g Application Aristocort 0.02% 1 3.23 4.75
Triamcinolone with Neomycin, Gramicidin and Nystatin Ear drops containing triamcinolone acetonide 1 mg with neomycin 2.5 mg (as sulfate), gramicidin 250 micrograms and nystatin 100,000 units per g, 7.5 mL Application to the ear Kenacomb Otic 1 3.78 5.36
Ear ointment containing triamcinolone acetonide 1 mg with neomycin 2.5 mg (as sulfate), gramicidin 250 micrograms and nystatin 100,000 units per g, 5 g Application to the ear Kenacomb Otic 1 1.42 3.00
Trimethoprim Tablet 300 mg Oral Triprim 7 1.58 3.12
Trimethoprim with Sulfamethoxazole Paediatric oral suspension 40 mg-200 mg per 5 mL, 100 mL Oral Septrin 1 2.03 5.47
Tablet 160 mg-800 mg Oral Septrin Forte 10 2.28 5.43
Valproic Acid Tablet (enteric coated) containing sodium valproate 200 mg Oral Epilim EC 100 6.40 7.33
Tablet (enteric coated) containing sodium valproate 500 mg Oral Epilim EC 100 12.67 13.60
Verapamil Tablet containing verapamil hydrochloride 80 mg Oral Isoptin 100 6.95 10.20
Tablet containing verapamil hydrochloride 180 mg (sustained release) Oral Isoptin 180 SR 30 5.61 8.86
Tablet containing verapamil hydrochloride 240 mg (sustained release) Oral Isoptin SR 30 7.48 10.73
Zolmitriptan Tablet 2.5 mg Oral Zomig 2 7.04 8.32

Schedule 2—Pharmaceutical benefits for which the Commonwealth will pay the special patient contribution

(section 7)

Listed Drug Form Manner of Administration Brand Circumstances
Amoxycillin Powder for paediatric oral drops 100 mg (as trihydrate) per mL, 20 mL Oral Amoxil Treatment of infections suspected or proven to be due to a susceptible organism in patients who require a liquid formulation and in whom the syrup formulations are unsuitable. 
Eprosartan Tablet 400 mg (as mesylate) Oral Teveten

Adverse effects occurring with all of the base‑priced drugs.

Drug interactions occurring with all of the base‑priced drugs. 

Drug interactions expected to occur with all of the base‑priced drugs.

Transfer to a base‑priced drug would cause patient confusion resulting in problems with compliance. 

Tablet 600 mg (as mesylate) Oral Teveten

Adverse effects occurring with all of the base-priced drugs.

Drug interactions occurring with all of the base-priced drugs.

Drug interactions expected to occur with all of the base-priced drugs.

Transfer to a base-priced drug would cause patient confusion resulting in problems with compliance.
Naratriptan Tablet 2.5 mg (as hydrochloride) Oral Naramig

Migraine attack in a patient where attacks in the past have usually failed to respond to analgesics, and where adverse events have occurred with other suitable PBS‑listed drugs. 

Migraine attack in a patient where attacks in the past have usually failed to respond to analgesics, and where drug interactions have occurred with other suitable PBS‑listed drugs.

Migraine attack in a patient where attacks in the past have usually failed to respond to analgesics, and where drug interactions are expected to occur with other suitable PBS-listed drugs.

Migraine attack in a patient where attacks in the past have usually failed to respond to analgesics, and where transfer to another suitable PBS‑listed drug would cause patient confusion resulting in problems with compliance.

Migraine attack in a patient where attacks in the past have usually failed to respond to analgesics, and where transfer to another suitable PBS‑listed drug is likely to result in adverse clinical consequences.   

Olmesartan Tablet containing olmesartan medoxomil 20 mg Oral Olmetec

Adverse effects occurring with all of the base-priced drugs.

Drug interactions occurring with all of the base-priced drugs.

Drug interactions expected to occur with all of the base-priced drugs.

Transfer to a base-priced drug would cause patient confusion resulting in problems with compliance. 

Tablet containing olmesartan medoxomil 40 mg Oral Olmetec

Adverse effects occurring with all of the base-priced drugs.

Drug interactions occurring with all of the base-priced drugs.

Drug interactions expected to occur with all of the base-priced drugs.

Transfer to a base-priced drug would cause patient confusion resulting in problems with compliance.

Endnotes

Endnote 1—About the endnotes

The endnotes provide information about this compilation and the compiled law.

The following endnotes are included in every compilation:

Endnote 1—About the endnotes
Endnote 2—Abbreviation key
Endnote 3—Legislation history

Endnote 4—Amendment history

Abbreviation key—Endnote 2

The abbreviation key sets out abbreviations that may be used in the endnotes.

Legislation history and amendment history—Endnotes 3 and 4

Amending laws are annotated in the legislation history and amendment history.

The legislation history in endnote 3 provides information about each law that has amended (or will amend) the compiled law. The information includes commencement details for amending laws and details of any application, saving or transitional provisions that are not included in this compilation.

The amendment history in endnote 4 provides information about amendments at the provision (generally section or equivalent) level. It also includes information about any provision of the compiled law that has been repealed in accordance with a provision of the law.

Editorial changes

The Legislation Act 2003 authorises First Parliamentary Counsel to make editorial and presentational changes to a compiled law in preparing a compilation of the law for registration. The changes must not change the effect of the law. Editorial changes take effect from the compilation registration date.

If the compilation includes editorial changes, the endnotes include a brief outline of the changes in general terms. Full details of any changes can be obtained from the Office of Parliamentary Counsel.

Misdescribed amendments

A misdescribed amendment is an amendment that does not accurately describe the amendment to be made. If, despite the misdescription, the amendment can be given effect as intended, the amendment is incorporated into the compiled law and the abbreviation “(md)” added to the details of the amendment included in the amendment history.

If a misdescribed amendment cannot be given effect as intended, the abbreviation “(md not incorp)” is added to the details of the amendment included in the amendment history.

Endnote 2—Abbreviation key

ad = added or inserted o = order(s)
am = amended Ord = Ordinance
amdt = amendment orig = original
c = clause(s) par = paragraph(s)/subparagraph(s)
C[x] = Compilation No. x     /sub‑subparagraph(s)
Ch = Chapter(s) pres = present
def = definition(s) prev = previous
Dict = Dictionary (prev…) = previously
disallowed = disallowed by Parliament Pt = Part(s)
Div = Division(s) r = regulation(s)/rule(s)
ed = editorial change reloc = relocated
exp = expires/expired or ceases/ceased to have renum = renumbered
    effect rep = repealed
F = Federal Register of Legislation rs = repealed and substituted
gaz = gazette s = section(s)/subsection(s)
LA = Legislation Act 2003 Sch = Schedule(s)
LIA = Legislative Instruments Act 2003 Sdiv = Subdivision(s)
(md) = misdescribed amendment can be given SLI = Select Legislative Instrument
    effect SR = Statutory Rules
(md not incorp) = misdescribed amendment Sub‑Ch = Sub‑Chapter(s)
    cannot be given effect SubPt = Subpart(s)
mod = modified/modification underlining = whole or part not
No. = Number(s)     commenced or to be commenced

Endnote 3—Legislation history

Name Registration Commencement Application, saving and transitional provisions
PB 109 of 2010 30 Nov 2010 (F2010L03136) 1 Dec 2010 (s 2)
PB 6 of 2011 28 Jan 2011 (F2011L00165) 1 Feb 2011 (s 2) —
PB 15 of 2011 23 Feb 2011 (F2011L00298) 1 Mar 2011 (s 2) —
PB 25 of 2011 25 Mar 2011 (F2011L00490) s 1–3: 26 Mar 2011
Sch 1: 1 Apr 2011
(s 2(1))
Sch 2: 2 Apr 2011
(s 2(2)) 		—
PB 43 of 2011 15 June 2011 (F2011L01051) 1 July 2011 (s 2) —
PB 50 of 2011 27 July 2011 (F2011L01546) 1 Aug 2011 (s 2) —
PB 58 of 2011 29 Aug 2011 (F2011L01763) 1 Sept 2011 (s 2) —
PB 75 of 2011 26 Oct 2011 (F2011L02131) 1 Nov 2011 (s 2) —
PB 84 of 2011 28 Nov 2011 (F2011L02476) 1 Dec 2011 (s 2) —
PB 2 of 2012 13 Feb 2012 (F2012L00272) 1 Mar 2012 (s 2) —
PB 14 of 2012 30 Mar 2012 (F2012L00723) s 1–3 and Sch 1: 1 Apr 2011 (s 2(1))
Sch 2: 1 Apr 2012
(s 2(2)) 		—
PB 28 of 2012 26 Apr 2012 (F2012L00936) 1 May 2012 (s 2) —
PB 45 of 2012 25 July 2012 (F2012L01599) 1 Aug 2012 (s 2) —
PB 61 of 2012 15 Aug 2012 (F2012L01682) 1 Sept 2012v —
PB 72 of 2012 27 Sept 2012 (F2012L01952) 1 Oct 2012 (s 2) —
PB 94 of 2012 29 Nov 2012 (F2012L02284) 1 Dec 2012 (s 2) —
PB 109 of 2012 18 Dec 2012 (F2012L02511) 1 Jan 2013 (s 2) —
PB 2 of 2013 10 Jan 2013 (F2013L00040) 1 Feb 2013 (s 2) —
PB 15 of 2013 26 Mar 2013 (F2013L00559) 1 Apr 2013 (s 2) —
PB 22 of 2013 23 Apr 2013 (F2013L00678) 1 May 2013 (s 2) —
PB 41 of 2013 29 July 2013 (F2013L01457 1 Aug 2013 (s 2) —
PB 54 of 2013 15 Aug 2013 (F2013L01579) 1 Sept 2013 (s 2) —
PB 62 of 2013 10 Sept 2013 (F2013L01681) 1 Oct 2013 (s 2) —
PB 75 of 2013 28 Nov 2013 (F2013L02007) 1 Dec 2013 (s 2) —
PB 89 of 2013 20 Dec 2013 (F2013L02169) 1 Jan 2014 (s 2) —
PB 2 of 2014 10 Jan 2014 (F2014L00052) 1 Feb 2014 (s 2) —
PB 18 of 2014 26 Mar 2014 (F2014L00356) 1 Apr 2014 (s 2) —
PB 28 of 2014 11 Apr 2014 (F2014L00400) 1 May 2014 (s 2) —
PB 37 of 2014 21 May 2014 (F2014L00589) 1 June 2014 (s 2) —
PB 53 of 2014 31 July 2014 (F2014L01063) 1 Aug 2014 (s 2) —
PB 73 of 2014 26 Sept 2014 (F2014L01289) 1 Oct 2014 (s 2) —
PB 89 of 2014 27 Nov 2014 (F2014L01597) 1 Dec 2014 (s 2) —
PB 11 of 2015 25 Feb 2015 (F2015L00208) 1 Mar 2015 (s 2) —
PB 27 of 2015 25 Mar 2015 (F2015L00333) 1 Apr 2015 (s 2) —
PB 40 of 2015 24 Apr 2015 (F2015L00590) 1 May 2015 (s 2) —
PB 48 of 2015 29 May 2015 (F2015L00763) 1 June 2015 (s 2) —
PB 69 of 2015 31 July 2015 (F2015L01204) 1 Aug 2015 (s 2) —
PB 79 of 2015 28 Aug 2015 (F2015L01352) 1 Sept 2015 (s 2) —
PB 91 of 2015 30 Sept 2015 (F2015L01537) 1 Oct 2015 (s 2) —
PB 102 of 2015 28 Oct 2015 (F2015L01703) 1 Nov 2015 (s 2) —
PB 108 of 2015 30 Nov 2015 (F2015L01874) 1 Dec 2015 (s 2) —
PB 118 of 2015 24 Dec 2015 (F2015L02131) 1 Jan 2016 (s 2) —
PB 2 of 2016 1 Feb 2016 (F2016L00073) 1 Feb 2016 (s 2) —
PB 19 of 2016 1 Apr 2016 (F2016L00478) 1 Apr 2016 (s 2) —
PB 30 of 2016 29 Apr 2016 (F2016L00600) 1 May 2016 (s 2) —
PB 42 of 2016 30 May 2016 (F2016L00861) 1 June 2016 (s 2) —

Endnote 4—Amendment history

Provision affected How affected
s 4........................................ am PB 72 of 2012
s 5........................................ rs PB 72 of 2012
s 6........................................ rs PB 72 of 2012
s 7........................................ am PB 58 of 2011; PB 72 of 2012
Schedule 1
Schedule 1........................... rs PB 6 of 2011
am PB 15, 25, 43, 50, 58, 75 and 84 of 2011; PB 2, 14, 28, 45 and 61 of 2012
rs. PB 72 of 2012
am PB 94 and 109 of 2012; PB 2, 15, 22, 41, 54, 62, 75 and 89 of 2013; PB 2, 18, 28, 37, 53, 73 and 89 of 2014; PB 11, 27, 40, 48, 69, 79, 91, 102, 108 and 118 of 2015; PB 2, 19, 30 and 42 (Sch 1 items 29, 30 md not incorp) of 2016
Schedule 2
Schedule 2........................... am PB 15 and 25 of 2011; PB 14 of 2012; PB 22, 41 and 62 of 2013; PB 53 of 2014
Actions
Download as PDF Download as Word Document
Cases Citing This Decision

0

Cases Cited

0

Statutory Material Cited

0